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Abstract
Scientific and medical research with children is essential to the 
development of therapies for younger patients. Paediatric biobanking uses
samples from minors to provide a critical and expanding resource for such
research. It also raises important ethical, legal and social implications 
(ELSI) and highlights the need for appropriate frameworks for practice 
developed through stakeholder consultation. This paper reviews the 
current literature on stakeholder views of paediatric biobanking. A 
narrative review was conducted of empirical studies in this area, the 
majority of which did not involve actual biobanks or include the views of 
children. Key themes were identified: parental consent; childrens’ assent; 
the return of results; and risks, benefits and burdens of participation. The 
resultant analysis highlights how children involved in paediatric biobanks 
are not only capable of understanding and assenting to their participation 
but also of contributing their voices to the development of future 
paediatric biobanking policy.
Key words: paediatric biobank, children, ethics, narrative review, genetic,
social
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1. Introduction
The use of human samples in biomedical research has resulted in 
unprecedented scientific breakthroughs (Wolf, Bouley et al. 2010). 
Biobanking technology today offers a rich resource for studying many 
aspects of human health and disease. The Organisation for Economic Co-
operation and Development defines biobanks as “a collection of biological 
material and the associated data and information stored in an organised 
system, for a population or a large subset of a population” (Sampogna 
2006). Paediatric biobanking promises greater understanding of the 
causes, prevention and treatment of childhood disease (Brisson, Matsui et 
al. 2012). The ongoing dearth of knowledge of preventive measures and 
appropriate treatment for children at different stages of their development
is internationally recognised (Gill 2004). This limitation results in part from
stringent child protection restrictions placed on research involving children
(Avard, Silverstein et al. 2009). But alongside the need for child protection
in research is an equal and growing need for the inclusion of child 
participants in order to generate age-specific findings (Field and Behrman 
2004). Paediatric biobanks continue to be developed as a basis for 
facilitating medical and scientific research with samples from child 
populations (Samuël, Knoppers et al. 2012). Their development has been 
accompanied by a corresponding interest in the ethics of children’s 
participation in research and a need for sociological inquiry into practices 
connected to it (Avard, Sénécal et al. 2011). Future understandings can be
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expected to aid in policy development and the implementation of 
culturally appropriate paediatric biobanking practices.
Paediatric biobanking is governed by myriad restrictions and regulations, 
an unsurprising situation given the historical injustices in bioscience 
perpetrated on vulnerable populations (Avard, Silverstein et al. 2009) and 
the controversial discovery of unconsented bio-repositories such as those 
at Alder Hey hospital and Bristol Royal Infirmary in the UK (Boden, Epstein 
et al. 2009, Avard, Sénécal et al. 2011). There is also ongoing limited 
guidance on promoting good biobanking practices involving samples from 
children (Samuël, Knoppers et al. 2012). In paediatric biobanking, 
participants are in a state of growing maturity requiring researchers to 
address issues of privacy, autonomy and concepts of risk that all change 
with age. Some argue that research on children should only be undertaken
if it involves no more than minimal risks, namely those no higher than 
what a child would encounter in daily life (Hens, Nys et al. 2009). A 
dynamic approach to paediatric biobanking has also been put forward
(Avard, Silverstein et al. 2009), one founded on continued communication 
among all stakeholders (for example, the model proposed by (Kaye, 
Whitley et al. 2014)). 
Children are key stakeholders and have demonstrable knowledge of the 
benefits and challenges of biobank participation (Anderson, Stackhouse et
al. 2011). Considering their views in research recognizes their worth as 
human beings (Roberts 2008) and potentially improves the protection of 
children while fostering trust in biobanking (Lemke, Wolf et al. 2010). Such
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consultation may also help highlight pitfalls in research design and 
provide opportunities for improving research (Godard, Marshall et al. 
2004). The UN Convention on the Rights of the Child states that children 
capable of forming their own views should be assured their right to 
express these views on matters concerning them (Morrow and Richards 
1996). The Children’s Act of 1989 in England and Wales stipulates that 
courts shall regard the wishes and feelings of the child, while professional 
bodies such as the British Psychological Association and the British 
Sociological Association as well as research organisations such as the 
Medical Research Council encourage active consultation and engagement 
with children involved in research.
Little is known, however, about children’s understandings of their social 
positioning within health research (Mayall 1998). Children are increasingly 
seen as competent social actors worthy of study in their own right (James 
and James 2001), and that understanding childhood requires revealing the
experiences of children (Shanahan 2007). But giving voice to children 
entails more than simply letting children speak; it necessitates a deeper 
exploration of their experiences and how adults theorise these (James 
2007). Understanding social order from a child’s standpoint requires 
studying not only a child’s perceptions but also the development of the 
concepts that underpin such knowledge (Mayall 1998). Social studies of 
paediatric biobanking is therefore needed to inform more fully policies 
affecting the study of health and disease in children (Grover 2004).
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While paediatric research must always be finely balanced against child 
protection (Mumford 1999), overweighting in favor of protectionism can 
result in ‘therapeutic orphans’ and a limited number therapies tested for 
safety and efficacy in children (Samuël, Ries et al. 2008). The construction
of children’s vulnerability may also lead some researchers to view child 
participants as ‘out-of-bounds’ with the result that their voices are 
silenced (Moran-Ellis 2010). Past efforts to advance research while 
maintaining effective child protection have rested on the principle of 
subsidiarity; that is, permitting research on children only if it cannot be 
done on adults (Hens, Van El et al. 2012). Research with children has also 
generally been based on the precautionary principle that adequate 
measures must be taken to avoid potentially harmful outcomes when 
there is an expectation based on empirical evidence or causal hypotheses 
that damage could occur (Jarosinska and Gee 2007). This approach 
demands full consideration be given to any physical and emotional harm 
to the child, such as avoiding venipuncture by using residual blood from 
diagnostic testing, or conducting data collection at home or a familiar 
setting rather than in a hospital (Avard, Silverstein et al. 2009). Risks 
specifically associated with biobank participation include breaches of 
privacy, the disclosure of information to third parties, and possible 
stigmatisation of participants based on genetic results (Avard, Silverstein 
et al. 2009).
The objective of this paper is, therefore, to identify and critically review 
existing empirical research into the views and perspectives of principal 
stakeholders involved in paediatric biobanking – namely children, parents 
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and researchers. The authors aim to summarise not only key findings 
emerging from this literature, but also to critically examine higher level 
ethical, legal and social implications (ELSI) issues cross cutting the 
existing evidence base. The authors assume from the outset that 
children's voices are essential to future development of paediatric 
biobanking policies and best practice. 
2. Methods
A narrative approach was used to review the literature. The aim was to 
identify empirical research involving stakeholders and/or participants in 
paediatric biobanks. A narrative rather than systematic review was 
undertaken for reasons outlined in the literature (Petticrew and Roberts 
2008, Bryman 2012), namely: that the focus of the review was broad 
rather than specific; the studies under consideration were largely 
qualitative or mixed methods; and the objective was to assess individual 
studies rather conduct a meta-analysis. A literature search was conducted
by the lead author (CO) to identify all articles published in English prior to 
May 2014 using multiple bibliographic databases. The search process was 
iterative and continued until no new articles were found (Petticrew and 
Roberts 2008). The overall strategy was additionally reviewed for quality 
and output by a second author (JM), who is a professional librarian.
In order to pinpoint search terms most applicable in the field of paediatric 
biobanking, an initial pilot search was conducted using the Web of 
Knowledge (WoK) bibliographic database. An analysis of the results from 
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exploratory searching determined that virtually all relevant papers 
included keywords on two themes: children and genetic databases. There 
was, however, considerable variation in terminology use. The terms 
relating to children were child/children, minor, youth, young people, 
adolescent and paediatric; while those relating to genetic databases were 
biobank(s), gene bank(s), gene repository/ies, genetic database(s), stored
DNA and genomic database(s). Based on these pilot efforts, an initial 
search was conducted in WoK using the terms identified above for children
and genetic databases. The final search used was: 
TOPIC: (child* OR minor OR youth OR young people OR adolescent OR 
paediatric) AND 
TOPIC: (biobank* OR gene bank* OR gene repositor* OR genetic 
database* OR stored DNA OR genetic repository* OR genomic database*)
The search (along with all subsequent updating searches) was conducted 
without date restrictions because paediatric biobanking remains a 
relatively new practice whose documented evidence base is small. Initially
we focused on general population biobanks that either included mainly or 
only children. As these efforts yielded few papers, it was decided that 
disease-specific tissue banks should also be included to elicit a range of 
views about children’s participation in biobanking more broadly.
The final WoK search (May 2014) produced 311 unique hits. These were 
assessed by reviewing each paper’s keywords and abstract using 
predefined inclusion and exclusion criteria. Papers were included for 
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review if they reported findings from empirical studies into people’s 
opinions, views, perceptions or experiences with a paediatric biobank, 
paediatric tissue bank, or any biobank and tissue bank including or 
intended to include samples from children. Papers excluded from review 
were those of a medical laboratory nature, those detailing the structures 
of biobanks, any papers based on blood spots or Guthrie cards, those 
focusing on predictive genetic screening, and publications not based on 
empirical studies (e.g. theoretical papers, systematic reviews, legal 
document reviews). Papers were also excluded from review if they were 
not published in English or if full-text versions could not be obtained. 
Some papers included for review sought participants’ views on the idea of 
paediatric biobanking rather than actual paediatric biobanks. For the 
purposes of this paper these were categorised as being “hypothetical” 
biobanks owing to the fact that the biobanks either did not exist or were 
being established but not yet operational. 
The WoK search was then repeated in PubMed (119 hits) and Scopus (195 
hits). A total of 11 articles met the inclusion criteria. Following all three 
searches, a similar and final search was conducted using Google Scholar 
(GS). Because GS offers a less precise search interface, the search 
strategy incorporated additional terms relating to research methods and 
study type. Of the terms used, the first was ‘paediatric biobank’, the 
second focused on research methodology (e.g. qualitative, empirical, 
thoughts, views, experiences) and the third related to study type (e.g. 
birth cohort, longitudinal). Within GS the final search used was:
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paediatric biobank AND qualitative OR empirical OR thoughts OR views 
OR experiences AND longitudinal birth cohort 
Two further articles were identified using GS. To ensure a comprehensive 
literature review, a ‘pearl growing’ (Bryman 2012) assessment of the 
references cited in all 13 articles was carried out. This produced two 
further articles that met the inclusion criteria, for a total of 15. 
When conducting a narrative review, Bryman (Bryman 2012) also 
recommends reviewing key authors’ publications. Based on papers 
assessed for inclusion, several researchers were identified as prominent in
the broader field of paediatric biobanking through their involvement in 
either empirical or theoretical research. A search for each was conducted 
in WoK and PubMed, identifying one further paper. Corresponding authors 
of all 16 papers were contacted by CO to inquire if further work had been 
completed or published. This yielded six papers for a total of 22. Emails 
were also sent to 70 paediatric biobanks and biobanks involving families 
requesting references, though no new articles meeting the inclusion 
criteria were identified.
3. Results
The results section first provides a brief overview of the papers and the 
different types of research undertaken. Secondly we identify four main 
themes emerging from the findings and considers their implication for 
future research and practice in paediatric biobanking. 
3.1. Summary of papers reviewed
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All papers reviewed are summarised in Table 1. Four key characteristics 
were identified among them. First, the 22 papers reported only 17 
empirical studies (papers reporting on single underlying studies were: 
Study A (Halverson and Ross 2012, Lemke, Halverson et al. 2012); Study B
(Goodenough, Williamson et al. 2003, Goodenough, Williamson et al. 
2004, Williamson, Goodenough et al. 2004); and Study C (Hens and 
Dierickx 2010, Hens, Nys et al. 2010). Second, only one study sought 
solely children’s views about their experience of participating in biobank 
research (Goodenough, Williamson et al. 2003, Goodenough, Williamson 
et al. 2004). Two others (Dixon-Woods, Wilson et al. 2008, Harris, Ziniel et 
al. 2012) included both children and adults, though these were based on 
tissue bank research (i.e. disease specific biobanks); in these papers the 
contribution of children was not made explicit in the findings. One study 
included adolescents (i.e. children in their teens) as well as adults (Hens 
and Dierickx 2010, Hens, Nys et al. 2010). Third, a clear majority of the 
papers (n=13) involved what we have termed hypothetical paediatric 
biobanks (i.e. biobanks that did not exist at the time of the study). Finally, 
almost all authors referred to children, minors or adolescents without 
specifying age ranges (for this paper, we use child or children to refer to 
any individual under 18 unless specified otherwise by an author).
3.2. Themes arising from the review
Four main themes emerged from the literature reviewed on paediatric 
biobanks. These were: (1) parental consent; (2) children’s assent; (3) 
return of genetic results; and (4) risks, burdens and benefits of 
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participation. Each is discussed in turn, after which we briefly compare the
perspectives of the range of stakeholders involved in the reviewed 
studies.
3.2.1.Parental consent
Parental consent was a recurrent theme in many of the papers. Although 
never defined explicitly, parental consent was understood as parents’ 
agreement that samples, medical records and other information about 
their children would come to be included in biobanks as well as agreement
to their child’s ongoing participation. Consent was portrayed as a legally 
binding agreement given by a parent or a child who had reached the age 
of majority (usually age 16 years). Overall there was a general preference 
for involvement in biobanks that used broad consent and simple consent 
forms (Lemke, Halverson et al. 2012). While seeking views of women 
about a hypothetical paediatric biobank Neidich et. al. (2008) found that 
women supported the use of samples for a wide array of paediatric 
conditions, either to help their own children or medical science more 
generally. There was some variability regarding temporal restrictions on 
broad consent, with some studies suggesting parents preferred re-contact 
about future research (Lemke, Halverson et al. 2012), while others 
indicated a more general willingness to sanction future research without 
being re-contacted (McMurter, Parker et al. 2011). 
Contrary to common practice in consent taking, parents reported a 
preference for more straightforward and uncomplicated consenting 
procedures particularly in the nature of the consent forms (Hens and 
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Dierickx 2010). For example, a study proposing a hypothetical biobank
(McMurter, Parker et al. 2011) found that parents of paediatric oncology 
patients would be satisfied to give a simple ‘yes/no’ consent to future 
research without the need for complicated consent forms. Another (Hens 
and Dierickx 2010) found researchers and healthcare professionals in 
genetic research believed that parents would have less confidence in 
research and be less likely to participate in paediatric biobanks if 
presented with long consent forms, suggesting more complex consent 
forms could possibly deter participation among parents. 
Parental consent on behalf of children was seen as potentially 
problematic. Professionals in the field of genetics felt that proxy consent 
(consent given by parents on behalf of children) could infringe on the 
child’s rights by limiting the scope of the child’s assent (Hens, Snoeck et 
al. 2010). Williamson et. al. (2004) postulated that power is negotiated 
between parents and children in a complex manner and that the position 
of children changes as they age and acquire more information.
3.2.2.Children’s assent
Children’s assent was seen as the inclusion of a child’s permission – or 
more simply, a child’s agreement – to participate in research, once 
parental consent had been given on behalf of the child. All papers 
reported that children’s views needed to be taken into account as part of 
paediatric biobanking practices. In particular, this theme identified a 
debate over how assent was managed empirically. The issues identified 
included: when to presume consent (age versus maturity) (Hens and 
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Dierickx 2010); how to assent (Jackson, Dixon‐Woods et al. 2009); whether
to re-contact children to update consent (Goldenberg, Hull et al. 2009); 
and whether to make provisions for withdrawal from research (Ries, 
LeGrandeur et al. 2010). In their study involving parents of paediatric 
oncology patients, McMurter et. al. ( 2011) found that parents considered 
children capable of consent before the age of 18. Jackson et. al. (2009) 
affirmed this finding in their study of healthcare professionals but 
additionally found that strict formal adherence to assessing a child’s 
capacity (such as requiring his/her signature or having a particular age set
for majority) could interfere with the assessment of the child’s ability to 
consent. Hens et. al. (2010) corroborated this finding in their study of 
professionals involved in paediatric biobanking, although their main 
departure from Jackson was their suggestion that 16 to 18 is a suitable 
age for children to consent. Jackson et al (2009) argued that specific age 
boundaries for consenting were too restrictive. Hens et al (2010) did, 
however, acknowledged the impracticality of assigning a fixed threshold 
for consent given the influence of an individual child’s maturity and social 
context. Williamson et. al. (2004) reported that child participants viewed 
consent as a progressive relationship between themselves, their parents 
and researchers. Hens and Dierickx (2010) postulated that consent forms 
as used today mainly serve as a document for avoiding prosecution or 
litigation rather than being a document to improve patient-researcher 
relationship. Williamson et al. (2004) affirmed in their research with child 
participants of a biobank that children were cognisant of their changing 
priorities and opinions and could hence discuss their perceptions of their 
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own development logically. Additionally, in the case of long-term 
paediatric biobanking, competence and autonomy were thought to 
develop through direct social experience  (Hens and Dierickx 2010).
Kaufman et. al. (2008) demonstrated that adults saw the importance of 
obtaining children’s permission before inclusion in a biobank. Using a 
hypothetical scenario approach, Hens and Dierickx (2010) found that 
teenagers wanted to be re-contacted when participating in research for 
reasons of respect and curiosity rather desire to control the research. The 
issue of re-contact for consent was also reported by Goldenberg et. al.
(2009), who surveyed adult cancer patients about a hypothetical 
paediatric biobank that would include a sample from their childhood; in 
this case re-consent was seen primarily by respondents as indicative of 
the researchers’ respect for participants’ interest in research decision 
making. The debate on re-consent was presented as moving in tandem 
with a participant’s ability to withdraw from a study (2008). While the 
right to withdraw upheld an individual’s autonomy, it also restricted the 
potential for long term research. One reported way of avoiding high rates 
of withdrawal was to design participation in biobanks that allowed 
participants to waive future consent (Goldenberg, Hull et al. 2009). 
Williamson et. al. (2004) reported that some children felt pressure against 
dissenting to research participation in their study among child participants
of a biobank.
3.2.3.Return of results to children or families
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Also identified in the analysis was a desire for the return of research 
results in paediatric biobanking (McMurter, Parker et al. 2011). There was 
variation in participants’ expectations by way of returned results and how 
these would be communicated. Parents generally wanted some degree of 
feedback. For example, Harris et. al. (2012) found parents who had 
enrolled their children (with developmental disorders) in a tissue bank not 
only wanted to receive results but preferred to receive this information 
electronically, believing the results would help them understand their 
child’s condition more fully. Additionally, Hens and Dierickx (2010) found 
that even though participants understood there to be a clear distinction 
between research and diagnosis, return of results was considered a 
humane act as compensation for research participation. 
Although parents generally wanted results returned, this desire led to 
secondary concerns, especially tensions between a child’s autonomy and 
privacy vis-a-vis his/her parents (Hens and Dierickx 2010). The study 
found there was a need to strike a balance between a parent’s desire for 
disclosure and a child’s autonomy within research participation. This 
debate was also addressed by Hens et. al. (2010), who argued that 
communicating genetic results that lacked immediate medical value to 
parents would breach the principle of autonomy and affect the child’s 
ability for self-governance. In addition to this, Harris et. al. (2012) 
postulated that a child’s future autonomy in controlling their research 
results may be compromised when such results are disclosed to his/her 
legal guardian. Similarly, Hens and Dierickx  (2010) argued that the rights 
of a child to know about (potentially treatable) medical conditions 
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superseded the rights of his/her guardians in deciding not to know. 
Likewise, it was reported that returning genetic results could alter how 
parents treat their child (Hens, Nys et al. 2010). Such debates speak to 
ongoing concerns about best practices for upholding the autonomy of a 
child in paediatric biobanking.
3.2.4.Risks, burdens and benefits of participation
The final theme addressed the balance between the risks and burdens of 
research and the potential benefits that could come from participation. 
While definition of terms such as risks, burdens and benefits was rarely 
made explicit in the papers, risks were mainly viewed as potential harms, 
burdens as excessive demands in time and effort, and benefits as possible
gains from participation (including but not limited to financial or 
therapeutic gains). In the papers reviewed, the specific risks faced by 
children from biobanking were varied, from physical or emotional harm (a 
commonly reported example was venepuncture, though whether this 
meets the minimum risk threshold for child research participation may be 
debatable), to being uncomfortable socially with certain questions (e.g. 
questions about alcohol consumption among teenagers) (Hens and 
Dierickx 2010). 
A number of authors reported concern among researchers and the public 
to avoid risks and burdens for research participants. Others reported a 
similar finding among parents and children. Halverson and Ross (2012) 
specifically noted parents stating they would enrol their children in a 
biobank on condition of minimal risk to the children. Kaufman et. al.
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(2008) found parents in their study were not willing to enrol their children 
in biobanks because participation would be burdensome, especially if the 
biobank required daily recording of a child’s life, vis a vis the already long 
list of activities of their children. Hens et. al. (2010) reported that the 
possibility of research being distressing or of limited benefit to 
participants could inhibit enrolment in biobanks. Public opinion, as 
presented by Kaufman et. al. (2008), revealed an expectation of benefits 
to individuals such as the child or the child’s family, or a wider benefit to 
society through the advancement of medical knowledge. In spite of 
participants being concerned by the level of burden placed on them by 
participation, Lemke et. al. (2012) also found that parents believed the 
benefits of participating in a paediatric biobank outweighed the risks. 
Although parents wished to protect their children from unwarranted 
burden and risks, they were aware that certain risks are ubiquitous in 
society; and reasoned that no research is exempt from risk in the form of 
breaches (Lemke, Halverson et al. 2012).
4. Multiple stakeholders
A range of stakeholder opinions were covered in the papers included in 
this review. We note the specific patterns of these perspectives here. In 
papers reporting researchers’ opinions, the issues resonating most were 
the need for both parental consent and child’s assent (Jackson, Dixon‐
Woods et al. 2009, Hens and Dierickx 2010), the problematic nature of 
both blanket consent (Ries, LeGrandeur et al. 2010) and the return of 
research results (Ries, LeGrandeur et al. 2010), the need for privacy 
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protection, and a concern that research should not be burdensome to the 
child (Hens, Snoeck et al. 2010). Papers reporting views of parents 
demonstrated that there was a general desire to receive research results
(McMurter, Parker et al. 2011, Harris, Ziniel et al. 2012, Lemke, Halverson 
et al. 2012) and that children should be re-contacted as they matured
(McMurter, Parker et al. 2011) for consent (Klima, Fitzgerald-Butt et al. 
2013). Parents supported biobank use for a wide array of paediatric 
research (Neidich, Joseph et al. 2008) and their enrolment was based on 
their trust in biobanks (Neidich, Joseph et al. 2008, Brothers and Clayton 
2012). Parents asserted that children should be given access to their 
health records (Halverson and Ross 2012). Papers reporting the views of 
the public had similar themes: the need for re-consenting after the child 
reaches majority (Kaufman, Geller et al. 2008, Goldenberg, Hull et al. 
2009), the need for minimising a child’s pain and burden in participation
(Kaufman, Geller et al. 2008), a desire to receive research results
(Halverson and Ross 2012), and the importance of trust in research 
participation (Halverson and Ross 2012). Papers involving both 
adolescents and adults (who were not participants in biobanks) reported 
similar findings, (though it is not clear which responses were from the 
adults and which ones were from the adolescents): that research should 
not be burdensome (Hens and Dierickx 2010); a trust in parents ability to 
consent to the right research as well as trust in biobanking (Hens, Nys et 
al. 2010); the importance of informed consent and growth toward 
autonomy (Hens and Dierickx 2010, Hens, Nys et al. 2010); the need for 
confidentiality; and, wanting meaningful research results communicated
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(Hens, Nys et al. 2010). Papers reporting the views of children alone or 
children and parents (actual biobank participants) expressed the need for 
both child’s assent and parental consent (Goodenough, Williamson et al. 
2004, Williamson, Goodenough et al. 2004) the need for anonymity
(Goodenough, Williamson et al. 2004) and the growing autonomy of 
children (Goodenough, Williamson et al. 2004).
Discussion
This review highlighted four main areas of interest in paediatric 
biobanking. First, parents preferred simple consenting procedures, though 
it was noted that broad parental consent can be problematic if it impairs a
child’s future autonomy and control over their participation in research. 
Second, children’s assent was considered important in research. The few 
children interviewed in these empirical studies viewed their role in assent 
as a progressive relationship between themselves, their parents, the 
researchers. Child participants expected that with increasing age they 
would have more control over their research participation. There was, 
however, varied opinion as to the correct age for children to assume 
consenting responsibilities for research. Many child respondents held the 
view that children might find it difficult to exercise their right to dissent to 
research consented by their parents. Third, the return of research results 
is a particularly important issue. Parents generally wanted to receive 
results, viewing them as a possible benefit of participation in a biobank. 
Some authors however understood this activity as having the capacity to 
infringe upon a child’s autonomy. Finally, concern about risks, burdens and
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benefits of research participation was evident in the literature. 
Respondents in all studies wanted research to involve minimal risks and to
not be burdensome. Parents supported biobank participation on condition 
that the associated benefits outweighed the risks.
That consent and assent continue to be debated in paediatric research 
literature is unsurprising. While assent as defined by Alderson (2007) 
comprises a non-refusal or simple agreement without the understanding, 
discretion and legal validity associated with consent, consent invokes 
protection of one’s integrity of body, mind and personal information (Miller
and Boulton 2007). The latter is a concept with a dual ethical and legal 
nature (Brothers 2011). The consenting process in a paediatric research 
setting is ideally fashioned as a tripartite relationship between parents, 
children and researchers, though more probably involves value judgments
by the parent or child’s guardian rather than risk assessment or 
acceptance by the child. This is especially true where children are very 
young (e.g. in a birth cohort study) and parents give proxy consent based 
on a substituted judgment (i.e. the presumed judgment of child if he or 
she was competent) (Samuël, Knoppers et al. 2012). There is, of course, 
no guarantee that the guardian’s decision is the same as the child’s will. 
As children age it is necessary to examine their views on the consenting 
process to unlock pragmatic and ethical ways of handling this necessarily 
dynamic and changing relationship. Indeed, there are numerous examples
in the field of paediatric biobanking of potentially good practice, though 
these are not often documented or verified by or with child participants 
themselves. 
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Understandable concerns about the potential risks of research 
participation in this literature raise issues about definitions and 
perceptions of risk. Framing potential dis-benefits of research as risks may
be itself problematic: absence of risk is not commensurate with the 
absence of cost (Williams 2012). There may, for example, be relational or 
power impacts or costs. In as much as dissent is available for children – 
they are able to interpret social behaviour and develop social expectations
of themselves (Davis 1998) – such dissent may be difficult in practical and
emotional terms. A child’s dissent may be treated as non-cooperation; and
could bear a cost in the relational dynamic within the tripartite 
relationship, a relationship involving important power negotiations. 
Arguably, inequalities of power will always exist for children involved in 
research (Harden, Scott et al. 2000). While children are active social 
agents, their lives are in many ways determined for them (Neale and 
Smart 1998). The aim of including children in research and in debates 
about research is to avoid the situation whereby ‘children have a voice but
adults control the conversation’ (Shanahan 2007). Irwin (2006) proposed 
handling this power imbalance in research through the use of an 
emancipatory model; one having the capacity to increase the children’s 
influence over research without necessarily suggesting that the children 
should take over the research as is the case with participatory action 
research (Alderson 2007). Emancipatory research within paediatric 
biobanking addresses issues of power and respect and has the potential to
inform its practice by taking into account the children’s’ perspectives on 
the research.
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The return of research results is keenly debated in the broader literature 
about biobanking. Guidelines for return of results routinely recommend 
that results should only be returned if they have analytic validity, clinical 
validity, and action-ability, and that the results themselves meet criteria 
related to severity of outcome (Hens, Van El et al. 2012, Knoppers, Zawati 
et al. 2012, Wolf, Crock et al. 2012). The return of results is sometimes 
viewed as a way of benefit sharing in research and by extension is an 
incentive for participation (Tabor, Brazg et al. 2011). In the papers 
reviewed here, parents in tissue banks expressed a belief that research 
participation lead to the development of new medications that could 
benefit them and their children. This perspective may propagate the 
expectation and misconception of therapeutic gain from research with a 
primarily scientific and non-therapeutic aim (Halverson and Ross 2012). In
population biobanks, the equivalent misconception may be of the 
potential diagnostic benefits of research participation (Clayton and Ross 
2006). Brothers (2011) argues that biobanks, especially those with de-
identifiable resources, are not designed with the aim of, or capacity for, 
returning health-related results; also referred to as incidental findings.
The studies in this review presented parental and adult perspectives that 
positioned children as lacking (if only in part) the capacity to make 
decisions about themselves and how they interact in the world. 
Historically, children have been viewed in contrast to adults, typically 
framed as victims or deviants when their views or performance differ from
those of adults (Hood, Kelley et al. 1996). Paediatric research has been 
known to ascribe incompetence to children in a similar fashion, with the 
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result that it is typically easier to prove a child’s incompetence than it is 
for them to display their competence. And yet by the age of 5 years, a 
child has already developed a lifelong understanding of self, others, 
relationships and time (Alderson 2007, Uprichard 2008). Alderson (2007) 
argues children not only value interpersonal relationships, but they also 
have the ability to act responsibly and maintain these relationships. 
Children display sensitivity about differences in age and are generally 
eager to grow older due to their anticipation of a change in status (Bühler-
Niederberger 2010). Ageing throughout childhood involves a relationship 
between body, self and society (Uprichard 2008). The creation and 
reproduction of youth sub-cultures selectively adopt and reject adult rules 
and interpretations (Shanahan 2007). Children appropriate information 
from the adult world and use it to constitute their own realities (Shanahan 
2007). Although children borrow their parents’ constructions (e.g. risk), 
they ultimately negotiate their own understandings (Hood, Kelley et al. 
1996). Swartling et. al. (2011) have argued that the development of 
appropriate frameworks for research with children will only occur when 
adequate opportunities are available for adults to consult with children 
and consider as valid children’s experiences and views. On this basis, the 
current literature on participant experience in paediatric biobanking is 
very much still in its infancy.
5. Conclusion
In as much as the papers under review identified key themes in the views 
of stakeholders’ participating in paediatric biobanks, very little of the 
evidence came from or could clearly be identified as coming from 
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children. Moreover, much of the literature involving children and scientific 
and medical research is more generally contextualised within ethical 
debates (Harden, Scott et al. 2000) and assumes a largely protectionist 
perspective (Shanahan 2007). This social construction of children’s 
vulnerability gives rise to the perception that children as research subjects
are ‘out-of-bounds’, with the result that their voices are silenced (Moran-
Ellis 2010). This situations propagates a dependency model and 
undermines the status of children as individuals in their own rights
(Shanahan 2007). While there remains a need to balance inclusion of 
children in research with their protection (Avard, Silverstein et al. 2009), it 
is important to consider how efforts made to protect children may 
unintentionally protect the power of adults. But the role of children in 
research is evolving and the shift from their being silent and obedient 
subjects to autonomous and articulate participants (Alderson 2007) 
means appropriate biobanking practices involving children will occur as 
this stakeholder group is actively consulted (Goodenough, Williamson et 
al. 2004). Children have sophisticated understanding of concepts and 
issues surrounding genetics (Anderson, Stackhouse et al. 2011) and can 
contribute to complex policy debates on the topic (Grover 2004). Their 
virtual absence from empirical research at present is a critical omission to 
future development of paediatric biobanking policy.
Limitations of the study
This paper examined stakeholders’ perceptions of paediatric biobanks by 
aggregating studies of general population biobanks involving mainly or 
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only children with studies of disease-specific tissue banks of the same age
group. Although this aggregation helped overcome the limited evidence 
base, our analysis was in turn unable to distinguish between possible 
differences in attitudes among stakeholders in biobanks and those among 
stakeholders in disease-specific tissues banks. Our findings suggested 
attitudes between the two groups converge towards similar themes, 
though this finding could be challenged as more studies emerge. Our 
analysis was also limited in that the majority of the studies included were 
based stakeholders’ hypothetical ideas rather than direct experience, and 
by the fact that the research designs of some studies suggested additional
unpublished findings which could not be identified.
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TABLE 1 SUMMARISING PAPERS REVIEWED
Authors Type of Biobank
 actual vs hypothetical
 population biobank vs tissue 
bank
Participants
Methodology Country Key Findings
Brothers and Clayton 
(2012), (Brothers, 
Westbrook et al. 
2013)
Hypothetical, Population 
biobank
Parents (n=65)
Interviews USA Parents supported an opt-out model biobank in children and would allow their own 
child's sample to be included.
Brothers, Westbrook 
et al. (2013)
Actual , Population biobank
Parents (n=237)
Interviews USA 32.9% of participants were familiar with opt-out biorepository, while 92.4% approve of 
it based on a brief description.
Dixon-Woods, Wilson 
et al. (2008) 
Actual, Tissue bank
Children and parents (n=72)
Interviews UK Participants considered themselves to be members of a trusted community where 
values and interests were shared.
Goldenberg, Hull et 
al. (2009)
Hypothetical, Tissue bank
Adults (n=1186)
Survey (tele-
phone)
USA 67% would not be concerned about the use of childhood samples upon reaching adult-
hood. Concerned respondents were more likely to be more private about their medical 
records, less trusting of medical researchers, or African-American. 
Goodenough, 
Williamson et al. 
(2003)
Actual, Population biobank
Children (n=23)
Focus groups UK Children aged 8-10 years had valuable contributions to offer on their perceptions of 
participation in non-therapeutic longitudinal research.
Goodenough, 
Williamson et al. 
(2004)
Actual, Population biobank
Children (n=40) 
Interviews + 
focus groups
UK Children have concerns over activities they are asked to take part in as research par-
ticipants. Research participation fostered a feeling of ‘being special’ among children.
Halverson and Ross 
(2012), (Halverson 
and Ross 2012)
Hypothetical, Population 
biobank
Parents (n=45)
Deliberative 
engagement + 
survey
USA There was strong interest in receiving results, which was a main motivator for partici-
pation. The trust they had on the research would determine their enrolment.
Halverson and Ross 
(2012), (Halverson 
and Ross 2012)
Hypothetical, Population 
biobank
Parents (n=45)
Deliberative en-
gagement + 
survey 
USA Most participants stated they would enrol themselves and their children in a biobank. 
Some opposed enrolling children, particularly children unable to consent. 
1
Harris, Ziniel et al. 
(2012)
Actual, Tissue bank
Parents (n=19)
Focus groups USA Parents hoped to receive research results that would help them better understand 
their children’s conditions or contribute to scientific knowledge. 
Hens and Dierickx 
(2010), (Hens, Nys et
al. 2010)
Hypothetical, Population 
biobank
Teenagers and adults (n=76)
Focus groups Belgium There was a willingness to contribute tissue to research. Participants thought there 
was need for confidentiality protections. People expected to receive results that could 
be relevant to them.
Hens and Dierickx 
(2010)
Hypothetical, Population 
biobank
Researchers (n=10)
Interviews Belgium, 
UK, 
Saudi-
Arabia
Long consent forms weren’t preferred. Proper privacy and data protection was a need. 
Good communication considered important. Research on children needed to be for 
pediatric conditions.
(Hens and Dierickx 
2010), Hens, Nys et 
al. (2010)
Hypothetical, Population 
Biobank
Teenagers and adults (n=76)
Focus groups Belgium Research had to benefit and not burden children. Parents needed to engage their 
children in the decision-making. There was a need for re-contact upon maturity.
Hens, Snoeck et al. 
(2010)
Hypothetical, Population 
biobank
Researchers (n=64)
Survey (Ques-
tionnaire) 
Belgium 76.5% thought children should assent when they can comprehend; 51% estimated this
to be aged16-18 years. 
Jackson, DIXON‐
WOODS et al. (2009)
Hypothetical, Tissue bank
Researchers (n=331)
Survey (Ques-
tionnaires)
UK 100% were in favour of using tissue samples from children with cancer for research. 
90% said both parent and child should consent. 94% supported ‘generic’ rather than 
‘specific’ consent. 
Kaufman, Geller et al.
(2008)
Hypothetical, Population 
biobank
Adults (n=141) 
Focus groups USA Respondents were concerned with: minimizing children's fear, pain, and burdens; 
whether to include young children; and how to obtain children's assent. 
Klima, Fitzgerald-Butt
et al. (2013)
Actual, Tissue bank
Children (n=378)
Survey
(Consent 
assessment 
form)
USA Parents understood consent for participation, purpose of study, and lack of direct ben-
efit. Conversely, they least understood the indefinite storage of DNA, possible risks of 
participation, and that study was not for therapy. 
Lemke, Halverson et 
al. (2012) 
Hypothetical, Population 
biobank
Parents (n=45)
Deliberative en-
gagement + 
survey 
USA Focus group themes were: interest in biobank participation, broad consent and re-con-
tact; trust in biobanking; and receiving research results. Survey data indicated same 
degree of interest in receiving results about themselves and their children. 
McMurter, Parker et 
al. (2011)
Hypothetical, Tissue banking
Parents (n=100)
Survey
(Questionnaire)
Canada 89% agreed to have tissue sent anywhere for paediatric aims. 76% would permit ge-
netic research even if no impact was anticipated. 41% would not allow painful, re-
search procedures, while 15% would allow regardless of the child's dissent. 
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Neidich, Joseph et al. 
(2008)
Hypothetical. Population 
biobank
Parents (n=239)
Survey (oral) USA Caucasians were the most willing to enroll their children into a pediatric biobank. Most 
respondents expressed optimism the results would yield significant benefits that would
be distributed fairly.
Papaz, Safi et al. 
(2012)
Actual, Tissue bank
Children and adults 
(n=3278)
Consent forms Canada Leading causes for refusal of consent were lack of interest in research 43%, feeling 
overwhelmed clinically 14%, and discomfort with genetics 11%.
Ries, LeGrandeur et 
al. (2010)
Actual, Population biobank
Researchers (n=14)
Interviews Canada, 
Denmark
, 
England, 
France, 
Netherla
nds, USA
None adopted blanket consent for future use of samples/data. Ethics review of new 
studies a common requirement. Studies following children past early childhood sought 
assent/consent as the child matured.
Williamson, Goode-
nough et al. (2004)
Actual, Paediatric biobank
Children (n=167)
Interviews + 
focus groups
UK Children’s views are important in research and yet they underestimate the amount of 
control they have in it. Questioned parental rights to long-term use of children’s sam-
ples.
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